542 related articles for article (PubMed ID: 21875910)
1. Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction.
Wenzel P; Knorr M; Kossmann S; Stratmann J; Hausding M; Schuhmacher S; Karbach SH; Schwenk M; Yogev N; Schulz E; Oelze M; Grabbe S; Jonuleit H; Becker C; Daiber A; Waisman A; Münzel T
Circulation; 2011 Sep; 124(12):1370-81. PubMed ID: 21875910
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II-induced vascular dysfunction depends on interferon-γ-driven immune cell recruitment and mutual activation of monocytes and NK-cells.
Kossmann S; Schwenk M; Hausding M; Karbach SH; Schmidgen MI; Brandt M; Knorr M; Hu H; Kröller-Schön S; Schönfelder T; Grabbe S; Oelze M; Daiber A; Münzel T; Becker C; Wenzel P
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1313-9. PubMed ID: 23520167
[TBL] [Abstract][Full Text] [Related]
3. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury.
De Ciuceis C; Amiri F; Brassard P; Endemann DH; Touyz RM; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2106-13. PubMed ID: 16100037
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory monocytes determine endothelial nitric-oxide synthase uncoupling and nitro-oxidative stress induced by angiotensin II.
Kossmann S; Hu H; Steven S; Schönfelder T; Fraccarollo D; Mikhed Y; Brähler M; Knorr M; Brandt M; Karbach SH; Becker C; Oelze M; Bauersachs J; Widder J; Münzel T; Daiber A; Wenzel P
J Biol Chem; 2014 Oct; 289(40):27540-50. PubMed ID: 25143378
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease.
Karbach S; Croxford AL; Oelze M; Schüler R; Minwegen D; Wegner J; Koukes L; Yogev N; Nikolaev A; Reißig S; Ullmann A; Knorr M; Waldner M; Neurath MF; Li H; Wu Z; Brochhausen C; Scheller J; Rose-John S; Piotrowski C; Bechmann I; Radsak M; Wild P; Daiber A; von Stebut E; Wenzel P; Waisman A; Münzel T
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2658-68. PubMed ID: 25341795
[TBL] [Abstract][Full Text] [Related]
6. Nox2+ myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1.
Molitor M; Rudi WS; Garlapati V; Finger S; Schüler R; Kossmann S; Lagrange J; Nguyen TS; Wild J; Knopp T; Karbach SH; Knorr M; Ruf W; Münzel T; Wenzel P
Cardiovasc Res; 2021 Jan; 117(1):162-177. PubMed ID: 32077922
[TBL] [Abstract][Full Text] [Related]
7. Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice.
Harrison CB; Drummond GR; Sobey CG; Selemidis S
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):429-34. PubMed ID: 19843095
[TBL] [Abstract][Full Text] [Related]
8. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.
Marchesi C; Rehman A; Rautureau Y; Kasal DA; Briet M; Leibowitz A; Simeone SM; Ebrahimian T; Neves MF; Offermanns S; Gonzalez FJ; Paradis P; Schiffrin EL
Cardiovasc Res; 2013 Mar; 97(3):562-70. PubMed ID: 23250918
[TBL] [Abstract][Full Text] [Related]
9. CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction.
Hausding M; Jurk K; Daub S; Kröller-Schön S; Stein J; Schwenk M; Oelze M; Mikhed Y; Kerahrodi JG; Kossmann S; Jansen T; Schulz E; Wenzel P; Reske-Kunz AB; Becker C; Münzel T; Grabbe S; Daiber A
Basic Res Cardiol; 2013 Nov; 108(6):386. PubMed ID: 24061433
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor γ, coactivator 1α deletion induces angiotensin II-associated vascular dysfunction by increasing mitochondrial oxidative stress and vascular inflammation.
Kröller-Schön S; Jansen T; Schüler A; Oelze M; Wenzel P; Hausding M; Kerahrodi JG; Beisele M; Lackner KJ; Daiber A; Münzel T; Schulz E
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1928-35. PubMed ID: 23788763
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor.
Wassmann S; Stumpf M; Strehlow K; Schmid A; Schieffer B; Böhm M; Nickenig G
Circ Res; 2004 Mar; 94(4):534-41. PubMed ID: 14699015
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia exaggerates adventitial inflammation and angiotensin II-induced abdominal aortic aneurysm in mice.
Liu Z; Luo H; Zhang L; Huang Y; Liu B; Ma K; Feng J; Xie J; Zheng J; Hu J; Zhan S; Zhu Y; Xu Q; Kong W; Wang X
Circ Res; 2012 Oct; 111(10):1261-73. PubMed ID: 22912384
[TBL] [Abstract][Full Text] [Related]
13. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.
Cruzado MC; Risler NR; Miatello RM; Yao G; Schiffrin EL; Touyz RM
Am J Hypertens; 2005 Jan; 18(1):81-7. PubMed ID: 15691621
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota Promote Angiotensin II-Induced Arterial Hypertension and Vascular Dysfunction.
Karbach SH; Schönfelder T; Brandão I; Wilms E; Hörmann N; Jäckel S; Schüler R; Finger S; Knorr M; Lagrange J; Brandt M; Waisman A; Kossmann S; Schäfer K; Münzel T; Reinhardt C; Wenzel P
J Am Heart Assoc; 2016 Aug; 5(9):. PubMed ID: 27577581
[TBL] [Abstract][Full Text] [Related]
15. Microsomal prostaglandin synthase-1-derived prostaglandin E2 protects against angiotensin II-induced hypertension via inhibition of oxidative stress.
Jia Z; Guo X; Zhang H; Wang MH; Dong Z; Yang T
Hypertension; 2008 Nov; 52(5):952-9. PubMed ID: 18824665
[TBL] [Abstract][Full Text] [Related]
16. Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47(phox) gene expression in response to angiotensin II.
Ni W; Zhan Y; He H; Maynard E; Balschi JA; Oettgen P
Circ Res; 2007 Nov; 101(10):985-94. PubMed ID: 17872466
[TBL] [Abstract][Full Text] [Related]
17. Genetic and Pharmacologic Inhibition of the Chemokine Receptor CXCR2 Prevents Experimental Hypertension and Vascular Dysfunction.
Wang L; Zhao XC; Cui W; Ma YQ; Ren HL; Zhou X; Fassett J; Yang YZ; Chen Y; Xia YL; Du J; Li HH
Circulation; 2016 Nov; 134(18):1353-1368. PubMed ID: 27678262
[TBL] [Abstract][Full Text] [Related]
18. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM
J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the activated protein-1 transcription factor JunD induces oxidative stress and accelerates age-related endothelial dysfunction.
Paneni F; Osto E; Costantino S; Mateescu B; Briand S; Coppolino G; Perna E; Mocharla P; Akhmedov A; Kubant R; Rohrer L; Malinski T; Camici GG; Matter CM; Mechta-Grigoriou F; Volpe M; Lüscher TF; Cosentino F
Circulation; 2013 Mar; 127(11):1229-40, e1-21. PubMed ID: 23410942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
